- Home
- SGMO vs TONX Comparison
SGMO vs TONX Comparison
Compare SGMO & TONX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SGMO | TONX |
|---|---|---|
| Founded | 1995 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.1M | 136.5M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | SGMO | TONX |
|---|---|---|
| Price | $0.43 | $2.19 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $4.71 | N/A |
| AVG Volume (30 Days) | ★ 5.5M | 517.1K |
| Earning Date | 11-06-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 7.29 |
| Revenue | ★ $32,875,000.00 | $7,760,000.00 |
| Revenue This Year | N/A | $526.82 |
| Revenue Next Year | N/A | $45.45 |
| P/E Ratio | ★ N/A | $0.30 |
| Revenue Growth | N/A | ★ 3760.70 |
| 52 Week Low | $0.38 | $2.11 |
| 52 Week High | $2.73 | $29.77 |
Technical Indicators
Market Signals| Indicator | SGMO | TONX |
|---|---|---|
| Relative Strength Index (RSI) | 40.60 | N/A |
| Support Level | $0.43 | N/A |
| Resistance Level | $0.49 | N/A |
| Average True Range (ATR) | 0.02 | 0.00 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 3.99 | 0.00 |
Price Performance
Historical ComparisonAbout SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About TONX TON Strategy Company
TON Strategy Co is a leader in interactive video-based sales applications, transforms how businesses attract and engage customers. The company's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. The segments of the company are MARKET.live and Go Fund Yourself, and it derives maximum revenue from MARKET.live segment.